Profile | GDS4284 / 228775_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 987.897 | 74 |
GSM687648 | Patient 402 control | 1267.25 | 77 |
GSM687653 | Patient 403 control | 623.064 | 68 |
GSM687658 | Patient 404 control | 1085.21 | 75 |
GSM687663 | Patient 411 control | 984.283 | 74 |
GSM687668 | Patient 422 control | 1173.99 | 76 |
GSM687673 | Patient 424 control | 1319.64 | 78 |
GSM687678 | Patient 425 control | 846.534 | 71 |
GSM687683 | Patient 427 control | 1328.21 | 78 |
GSM687688 | Patient 428 control | 1095.77 | 75 |
GSM687695 | Patient 441 control | 4877.79 | 94 |
GSM687699 | Patient 443 control | 1428.54 | 79 |
GSM687704 | Patient 444 control | 779.169 | 70 |
GSM687707 | Patient 448 control | 1166.34 | 77 |
GSM687712 | Patient 449 control | 1003.43 | 74 |
GSM687719 | Patient 450 control | 1679.8 | 82 |
GSM687724 | Patient 451 control | 1775.72 | 83 |
GSM687728 | Patient 452 control | 980.375 | 74 |
GSM687646 | Patient 401 treated 24h | 759.026 | 69 |
GSM687649 | Patient 402 treated 24h | 1152.56 | 76 |
GSM687665 | Patient 411 treated 24h | 823.601 | 71 |
GSM687651 | Patient 402 treated 4 weeks | 1208.47 | 76 |
GSM687667 | Patient 411 treated 4 weeks | 781.096 | 70 |
GSM687670 | Patient 422 treated 24h | 1223.1 | 77 |
GSM687671 | Patient 422 treated 4 weeks | 813.045 | 71 |
GSM687654 | Patient 403 treated 24h | 814.3 | 71 |
GSM687675 | Patient 424 treated 24h | 1694.79 | 82 |
GSM687685 | Patient 427 treated 24h | 1388.32 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 863.943 | 72 |
GSM687677 | Patient 424 treated 4 weeks | 1060.06 | 75 |
GSM687687 | Patient 427 treated 4 weeks | 691.71 | 68 |
GSM687692 | Patient 428 treated 4h | 886.003 | 72 |
GSM687716 | Patient 449 treated 4h | 1017.7 | 74 |
GSM687722 | Patient 450 treated 4h | 2028.72 | 84 |
GSM687680 | Patient 425 treated 24h | 1039.15 | 74 |
GSM687690 | Patient 428 treated 24h | 1085.08 | 76 |
GSM687700 | Patient 443 treated 24h | 2044.55 | 85 |
GSM687705 | Patient 444 treated 24h | 739.227 | 70 |
GSM687714 | Patient 449 treated 24h | 1095.11 | 76 |
GSM687721 | Patient 450 treated 24h | 4194.99 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 1194.28 | 77 |
GSM687694 | Patient 428 treated 4 weeks | 907.938 | 72 |
GSM687702 | Patient 443 treated 4 weeks | 844.658 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 953.674 | 74 |
GSM687723 | Patient 450 treated 4 weeks | 1436.51 | 79 |
GSM687661 | Patient 404 treated 4h | 1303.53 | 78 |
GSM687710 | Patient 448 treated 4h | 1326.02 | 79 |
GSM687726 | Patient 451 treated 4h | 1382.11 | 79 |
GSM687730 | Patient 452 treated 4h | 3051.06 | 90 |
GSM687660 | Patient 404 treated 24h | 3318.3 | 90 |
GSM687697 | Patient 441 treated 24h | 2541.26 | 87 |
GSM687709 | Patient 448 treated 24h | 1017.05 | 75 |
GSM687725 | Patient 451 treated 24h | 1945.98 | 84 |
GSM687729 | Patient 452 treated 24h | 1953.37 | 85 |
GSM687727 | Patient 451 treated 4 weeks | 1102.93 | 75 |
GSM687731 | Patient 452 treated 4 weeks | 757.016 | 70 |